Wide-spread Brain Alterations Early After the Onset of Crohn's Disease in Children in Remission-a Pilot Study

Overview

Journal Front Neurosci

Date 2024 Dec 18

PMID 39691628

Authors

Pavel Filip

Lubomir Vojtisek

Anna Marie Jicinska

Zdenek Valenta

Ondrej Horak

Matej Hrunka

Silvia Mangia

Shalom Michaeli

Petr Jabandziev

Affiliations

Soon will be listed here.

Abstract

Background: The research on possible cerebral involvement in Crohn's disease (CD) has been largely marginalized and failed to capitalize on recent developments in magnetic resonance imaging (MRI).

Objective: This cross-sectional pilot study searches for eventual macrostructural and microstructural brain affection in CD in remission and early after the disease onset.

Methods: 14 paediatric CD patients and 14 healthy controls underwent structural, diffusion weighted imaging and quantitative relaxation metrics acquisition, both conventional free precession and adiabatic rotating frame transverse and longitudinal relaxation time constants as markers of myelination, iron content and cellular loss.

Results: While no inter-group differences in cortical thickness and relaxation metrics were found, lower mean diffusivity and higher intracellular volume fraction were detected in CD patients over vast cortical regions essential for the regulation of the autonomous nervous system, sensorimotor processing, cognition and behavior, pointing to wide-spread cytotoxic oedema in the absence of demyelination, iron deposition or atrophy.

Conclusion: Although still requiring further validation in longitudinal projects enrolling larger numbers of subjects, this study provides an indication of wide-spread cortical oedema in CD patients very early after the disease onset and sets possible directions for further research.

References

Mangia S, Svatkova A, Mascali D, Nissi M, Burton P, Bednarik P . Multi-modal Brain MRI in Subjects with PD and iRBD. Front Neurosci. 2018; 11:709. PMC: 5742124. DOI: 10.3389/fnins.2017.00709. View

Van Limbergen J, Russell R, Drummond H, Aldhous M, Round N, Nimmo E . Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008; 135(4):1114-22. DOI: 10.1053/j.gastro.2008.06.081. View

Marques J, Kober T, Krueger G, van der Zwaag W, Van de Moortele P, Gruetter R . MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field. Neuroimage. 2009; 49(2):1271-81. DOI: 10.1016/j.neuroimage.2009.10.002. View

Winkler A, Ridgway G, Webster M, Smith S, Nichols T . Permutation inference for the general linear model. Neuroimage. 2014; 92:381-97. PMC: 4010955. DOI: 10.1016/j.neuroimage.2014.01.060. View

Fuhrmann D, Knoll L, Blakemore S . Adolescence as a Sensitive Period of Brain Development. Trends Cogn Sci. 2015; 19(10):558-566. DOI: 10.1016/j.tics.2015.07.008. View

Jabandziev P, Pinkasova T, Kunovsky L, Papez J, Jouza M, Karlinova B . Regional Incidence of Inflammatory Bowel Disease in a Czech Pediatric Population: 16 Years of Experience (2002-2017). J Pediatr Gastroenterol Nutr. 2020; 70(5):586-592. PMC: 7170436. DOI: 10.1097/MPG.0000000000002660. View

Sutton S, Magagnoli J, Cummings T, Hardin J . Association between thiopurine medication exposure and Alzheimer's disease among a cohort of patients with inflammatory bowel disease. Alzheimers Dement (N Y). 2019; 5:809-813. PMC: 6880128. DOI: 10.1016/j.trci.2019.10.002. View

Glasser M, Sotiropoulos S, Wilson J, Coalson T, Fischl B, Andersson J . The minimal preprocessing pipelines for the Human Connectome Project. Neuroimage. 2013; 80:105-24. PMC: 3720813. DOI: 10.1016/j.neuroimage.2013.04.127. View

Bao C, Liu P, Shi Y, Wu L, Jin X, Zeng X . Differences in brain gray matter volume in patients with Crohn's disease with and without abdominal pain. Oncotarget. 2017; 8(55):93624-93632. PMC: 5706823. DOI: 10.18632/oncotarget.21161. View

10.

Robinson E, Jbabdi S, Glasser M, Andersson J, Burgess G, Harms M . MSM: a new flexible framework for Multimodal Surface Matching. Neuroimage. 2014; 100:414-26. PMC: 4190319. DOI: 10.1016/j.neuroimage.2014.05.069. View

11.

Bao C, Liu P, Liu H, Wu L, Jin X, Wang S . Differences in regional homogeneity between patients with Crohn's disease with and without abdominal pain revealed by resting-state functional magnetic resonance imaging. Pain. 2016; 157(5):1037-1044. PMC: 4969077. DOI: 10.1097/j.pain.0000000000000479. View

12.

Ji J, Spronk M, Kulkarni K, Repovs G, Anticevic A, Cole M . Mapping the human brain's cortical-subcortical functional network organization. Neuroimage. 2018; 185:35-57. PMC: 6289683. DOI: 10.1016/j.neuroimage.2018.10.006. View

13.

Nair V, Beniwal-Patel P, Mbah I, Young B, Prabhakaran V, Saha S . Structural Imaging Changes and Behavioral Correlates in Patients with Crohn's Disease in Remission. Front Hum Neurosci. 2016; 10:460. PMC: 5025433. DOI: 10.3389/fnhum.2016.00460. View

14.

Elsehety A, Bertorini T . Neurologic and neuropsychiatric complications of Crohn's disease. South Med J. 1997; 90(6):606-10. DOI: 10.1097/00007611-199706000-00005. View

15.

Gray M, Chao C, Staudacher H, Kolosky N, Talley N, Holtmann G . Anti-TNFα therapy in IBD alters brain activity reflecting visceral sensory function and cognitive-affective biases. PLoS One. 2018; 13(3):e0193542. PMC: 5843226. DOI: 10.1371/journal.pone.0193542. View

16.

Mackner L, Clough-Paabo E, Pajer K, Lourie A, Crandall W . Psychoneuroimmunologic factors in inflammatory bowel disease. Inflamm Bowel Dis. 2010; 17(3):849-57. DOI: 10.1002/ibd.21430. View

17.

Bonaz B, Rivest S . Effect of a chronic stress on CRF neuronal activity and expression of its type 1 receptor in the rat brain. Am J Physiol. 1998; 275(5):R1438-49. DOI: 10.1152/ajpregu.1998.275.5.R1438. View

18.

Button K, Ioannidis J, Mokrysz C, Nosek B, Flint J, Robinson E . Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci. 2013; 14(5):365-76. DOI: 10.1038/nrn3475. View

19.

Harms M, Somerville L, Ances B, Andersson J, Barch D, Bastiani M . Extending the Human Connectome Project across ages: Imaging protocols for the Lifespan Development and Aging projects. Neuroimage. 2018; 183:972-984. PMC: 6484842. DOI: 10.1016/j.neuroimage.2018.09.060. View

20.

Filip P, Svatkova A, Carpenter A, Eberly L, Nestrasil I, Nissi M . Rotating frame MRI relaxations as markers of diffuse white matter abnormalities in multiple sclerosis. Neuroimage Clin. 2020; 26:102234. PMC: 7139162. DOI: 10.1016/j.nicl.2020.102234. View